Asset Allocation

As of October 31, 2025.
Type % Net
Cash 0.00%
Stock 96.31%
Bond 0.00%
Convertible 0.00%
Preferred 1.29%
Other 2.40%
View Asset Allocation
Start Trial

Market Capitalization

As of October 31, 2025
Large 78.34%
Mid 19.64%
Small 2.01%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 86.50%    % Emerging Markets: 11.10%    % Unidentified Markets: 2.40%

Americas 5.93%
3.84%
Canada 3.84%
United States 0.00%
2.09%
Brazil 2.09%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 65.62%
United Kingdom 14.54%
46.64%
Denmark 4.52%
France 7.05%
Germany 7.79%
Ireland 6.75%
Netherlands 7.34%
Norway 1.71%
Spain 2.32%
Sweden 5.03%
Switzerland 4.14%
0.00%
4.43%
Israel 2.20%
South Africa 2.23%
Greater Asia 26.06%
Japan 8.75%
1.92%
Australia 1.92%
8.61%
Hong Kong 3.91%
Taiwan 4.70%
6.77%
China 3.92%
India 2.86%
Unidentified Region 2.40%

Stock Sector Exposure

Cyclical
24.51%
Materials
0.00%
Consumer Discretionary
7.97%
Financials
16.54%
Real Estate
0.00%
Sensitive
52.52%
Communication Services
8.76%
Energy
0.00%
Industrials
21.48%
Information Technology
22.28%
Defensive
20.70%
Consumer Staples
7.16%
Health Care
13.54%
Utilities
0.00%
Not Classified
2.27%
Non Classified Equity
0.00%
Not Classified - Non Equity
2.27%
As of October 31, 2025
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available